Documenting ViaCyte’s Stem Cell Diabetes Trial – A Sweet Life
A Sweet Life |
Documenting ViaCyte's Stem Cell Diabetes Trial
A Sweet Life Nearly 18 months into a breakthrough stem cell trial for type 1 diabetes, significant positive results are emerging. ViaCyte, a leader in stem cell therapies for diabetes, is conducting this first human trial of its kind. And a husband/wife team is … |
